NCT01135498View on ClinicalTrials.gov

A Study of Avastin (Bevacizumab) in Combination With Xelox and Tarceva in Patients With Metastatic Colorectal Cancer.

PHASE2CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions
Colorectal Cancer
Interventions
DRUG

bevacizumab [Avastin]

Intravenous repeating dose

DRUG

eloxatin

Intravenous repeating dose

DRUG

capecitabine [Xeloda]

Oral repeating dose

DRUG

erlotinib [Tarceva]

Oral repeating dose

Trial Locations (12)

22004

Huesca

23007

Jaén

25198

Lleida

26006

Logroño

39008

Santander

44002

Teruel

48903

Barakaldo

50009

Zaragoza

07198

Palma de Mallorca

08208

Sabadell, Barcelona

08221

Terrassa

09006

Burgos

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01135498 - A Study of Avastin (Bevacizumab) in Combination With Xelox and Tarceva in Patients With Metastatic Colorectal Cancer. | Biotech Hunter | Biotech Hunter